B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TPM4

MOLECULAR TARGET

tropomyosin 4

UniProt: P67936NCBI Gene: 71711 compounds

TPM4 (tropomyosin 4) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TPM4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Ergosterol0.691

About TPM4 as a Drug Target

TPM4 (tropomyosin 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented TPM4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TPM4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.